Jardiance 10 mg film-coated tablets, Placebo matching vicadrostat, BI 690517
1378-0041
Phase 3 small_molecule active
Quick answer
Jardiance 10 mg film-coated tablets, Placebo matching vicadrostat, BI 690517 for Type 2 diabetes, hypertension, cardiovascular disease is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Type 2 diabetes, hypertension, cardiovascular disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active